HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eptifibatide-induced profound thrombocytopenia.

Abstract
We report a case of profound thrombocytopenia, 2 hours following eptifibatide therapy which got reversed within 12 hours of discontinuation of eptifibatide.
AuthorsN Gupta, R Kapoor, S Bhandari
JournalIndian heart journal (Indian Heart J) 2004 May-Jun Vol. 56 Issue 3 Pg. 250-1 ISSN: 0019-4832 [Print] India
PMID15584573 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Glucocorticoids
  • Peptides
  • Platelet Aggregation Inhibitors
  • Dexamethasone
  • Eptifibatide
Topics
  • Coronary Angiography (adverse effects)
  • Dexamethasone (therapeutic use)
  • Eptifibatide
  • Glucocorticoids (therapeutic use)
  • Humans
  • Infusions, Intravenous
  • Middle Aged
  • Peptides (administration & dosage, adverse effects)
  • Platelet Aggregation Inhibitors (administration & dosage, adverse effects)
  • Prognosis
  • Thrombocytopenia (drug therapy, etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: